Typicality: | 0.325 |
Saliency: | 0.177 |
according to the drug regulator | 2 | other |
by 84.5% | 2 | other |
among women | 2 | transitive-object |
vaccine → reduce → the risk of cervical cancer | 5 |
vaccine → reduce → cervical cancer rates | 3 |
vaccine → reduce → the risk of cervical pre-cancer | 3 |
negative | neutral | positive |
0.110 | 0.598 | 0.292 |
Raw frequency | 11 |
Normalized frequency | 0.177 |
Modifier score | 0.500 |
Perplexity | 27.619 |